市場調査レポート

商品コード

1508808

バセドウ病市場：治療法別、投与経路別、流通チャネル別、地域別

Graves Disease Market By Treatment, By Route of Administration, By Distribution Channel, By Geography

出版日: 2024年06月18日 | 発行: Coherent Market Insights

| ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 671,625円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,044,750円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,492,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のバセドウ病市場は、2024年に4億1,010万米ドルと推定され、2024～2031年にかけてCAGR4.8％を示し、2031年には5億7,020万米ドルに達すると予測されます。

図1.バセドウ病市場シェア（%）、地域別、2024年

バセドウ病は、中毒性びまん性甲状腺腫としても知られ、甲状腺ホルモンの過剰分泌をもたらす自己免疫疾患です。甲状腺機能亢進症の最も一般的な原因です。バセドウ病は、免疫系が甲状腺を刺激して成長させ、甲状腺ホルモンを過剰に分泌させる抗体を作ることで発症します。過剰な甲状腺ホルモンは、体の多くの機能をスピードアップさせます。バセドウ病の一般的な症状には、震え、不安、体重減少、動悸、暑さに弱いなどがあります。バセドウ病は一般人口の約0.5％が罹患していますが、女性に多くみられます。この病気は遺伝的要素があると考えられており、しばしば家族内で発症します。バセドウ病は完治する病気ではないが、抗甲状腺薬、放射性ヨード治療、甲状腺の一部または全部を切除する手術によって効果的に治療することができます。

市場力学：

世界のバセドウ病市場の成長は、高齢化人口の増加や甲状腺疾患の有病率の増加といった要因によって牽引されています。米国甲状腺協会によると、バセドウ病は毎年米国人口の約0.5%が罹患しています。医療支出の増加、新しい治療オプションの利用可能性、病気の診断と管理に関する意識の高まりも市場成長の原動力となります。しかし、体重増加、脱毛、肝障害など、抗甲状腺薬に伴う副作用が市場成長の妨げとなる可能性があります。また、手術や放射性ヨード療法に伴う高コストも市場成長の妨げとなる可能性があります。新しい薬剤分子や併用療法に関する継続的な薬剤革新や臨床試験は、予測期間中に市場成長の有利な機会を提供する可能性があります。

本調査の主要特徴

当レポートでは、世界のバセドウ病市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模と複合年間成長率（CAGR%）を掲載しています。
異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界のバセドウ病市場における主要企業プロファイルを掲載しています。
本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界のバセドウ病市場レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界のバセドウ病市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

企業プロファイル
- AbbVie Inc.
- Pfizer Inc.
- RLC LABS, Inc.
- Merck KGaA
- Eisai Co., Ltd.
- Novartis AG
- Mylan NV
- Aspen Pharmacare Holdings Limited
- Sanofi
- GlaxoSmithKline plc
- AstraZeneca
- Horizon Therapeutics plc
- Alara Pharmaceutical Corporation
- Antares Pharma, Inc.
- Apitope Technology（Bristol）Ltd.
- IONIS Pharmaceuticals, Inc.
- Immunovant, Inc.
- HanAll Biopharma Co., Ltd.
- Cara Therapeutics

第10章アナリストの推奨事項

隆盛と衰退
一貫型機会マップ

第11章参考文献と調査手法

参考文献
調査手法

Product Code: CMI7060

Global graves' disease (overactive thyroid) market is estimated to be valued at USD 410.1 Mn in 2024 and is expected to reach USD 570.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

Figure 1. Graves' Disease (Overactive Thyroid) Market Share (%), By Region, 2024

Graves' disease, also known as toxic diffuse goiter, is an autoimmune disease that results in overproduction of thyroid hormones (hyperthyroidism). It is the most common cause of hyperthyroidism. Graves' disease develops when the immune system makes antibodies that stimulate the thyroid gland to grow and produce excess thyroid hormones. Excess thyroid hormones causes speeding up of many of the body's functions. Common symptoms of Graves' disease include tremors, anxiety, weight loss, heart palpitations, and heat intolerance. Graves' disease affects about 0.5% of the general population, although the disease is more common in women. The disease is believed to have a genetic component, and often runs in families. Although it is not curable, Graves' disease can be effectively treated by antithyroid medications, radioactive iodine therapy, or surgery to remove part or all of the thyroid gland.

Market Dynamics:

Global graves' disease (overactive thyroid) market growth is driven by factors like growing aging population and increasing prevalence of thyroid disorders. According to American Thyroid Association, Graves' disease affects about 0.5% of the population in the U.S. every year. Increasing healthcare expenditure, availability of newer treatment options, and rising awareness about disease diagnosis and management can also drive the market growth. However, side effects associated with antithyroid medications such as weight gain, hair loss and liver damage can hinder the market growth. High costs involved in surgeries and radioactive iodine therapy can also hamper the market growth. Ongoing drug innovations and clinical trials on newer drug molecules and combination therapies can offer lucrative opportunities for market growth over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global graves' disease (overactive thyroid) market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global graves' disease (overactive thyroid) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AbbVie Inc., Pfizer Inc., RLC LABS, Inc., Merck KGaA, Eisai Co., Ltd., Novartis AG, Mylan N.V., Aspen Pharmacare Holdings Limited, Sanofi, GlaxoSmithKline plc, AstraZeneca, Horizon Therapeutics plc, Alara Pharmaceutical Corporation, Antares Pharma, Inc., Apitope Technology (Bristol) Ltd., IONIS Pharmaceuticals, Inc., Immunovant, Inc., HanAll Biopharma Co., Ltd., Cara Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global graves' disease (overactive thyroid) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global graves' disease (overactive thyroid) market

Detailed Segmentation-

By Treatment
- Anti-thyroid Drugs
- Beta Blockers
- Iodine Therapy
- Radioactive Iodine Therapy
- Others
By Route of Administration
- Oral
- Parenteral
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AbbVie Inc.
- Pfizer Inc.
- RLC LABS, Inc.
- Merck KGaA
- Eisai Co., Ltd.
- Novartis AG
- Mylan N.V.
- Aspen Pharmacare Holdings Limited
- Sanofi
- GlaxoSmithKline plc
- AstraZeneca
- Horizon Therapeutics plc
- Alara Pharmaceutical Corporation
- Antares Pharma, Inc.
- Apitope Technology (Bristol) Ltd.
- IONIS Pharmaceuticals, Inc.
- Immunovant, Inc.
- HanAll Biopharma Co., Ltd.
- Cara Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Graves' Disease (Overactive Thyroid) Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Graves' Disease (Overactive Thyroid) Market, By Treatment, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Anti-thyroid Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Beta Blockers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Iodine Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Radioactive Iodine Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Graves' Disease (Overactive Thyroid) Market, By Route of Administration, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Graves' Disease (Overactive Thyroid) Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Graves' Disease (Overactive Thyroid) Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- RLC LABS, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eisai Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aspen Pharmacare Holdings Limited
- Sanofi
- GlaxoSmithKline plc
- AstraZeneca
- Horizon Therapeutics plc
- Alara Pharmaceutical Corporation
- Antares Pharma, Inc.
- Apitope Technology (Bristol) Ltd.
- IONIS Pharmaceuticals, Inc.
- Immunovant, Inc.
- HanAll Biopharma Co., Ltd.
- Cara Therapeutics

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

バセドウ病市場：治療法別、投与経路別、流通チャネル別、地域別

Graves Disease Market By Treatment, By Route of Administration, By Distribution Channel, By Geography

市場力学：

本調査の主要特徴

目次

第1章調査の目的と前提条件

第2章市場展望

第3章市場力学、規制、動向分析

第4章世界のバセドウ病市場-コロナウイルス（COVID-19）パンデミックの影響

第5章世界のバセドウ病市場、治療法別、2019～2031年、（100万米ドル）

第6章世界のバセドウ病市場、投与経路別、2019～2031年、（100万米ドル）

第7章世界のバセドウ病市場、流通チャネル別、2019～2031年（100万米ドル）

第8章世界のバセドウ病市場、地域別、2019～2031年、（100万米ドル）

第9章競合情勢

第10章アナリストの推奨事項

第11章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Graves' Disease (Overactive Thyroid) Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Graves' Disease (Overactive Thyroid) Market, By Treatment, 2019 - 2031, (USD Mn)

6. Global Graves' Disease (Overactive Thyroid) Market, By Route of Administration, 2019 - 2031, (USD Mn)

7. Global Graves' Disease (Overactive Thyroid) Market, By Distribution Channel, 2019 - 2031, (USD Mn)

8. Global Graves' Disease (Overactive Thyroid) Market, By Region, 2019 - 2031, (USD Mn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

バセドウ病市場：治療法別、投与経路別、流通チャネル別、地域別

Graves Disease Market By Treatment, By Route of Administration, By Distribution Channel, By Geography

市場力学：

本調査の主要特徴

目次

第1章 調査の目的と前提条件

第2章 市場展望

第3章 市場力学、規制、動向分析

第4章 世界のバセドウ病市場-コロナウイルス（COVID-19）パンデミックの影響

第5章 世界のバセドウ病市場、治療法別、2019～2031年、（100万米ドル）

第6章 世界のバセドウ病市場、投与経路別、2019～2031年、（100万米ドル）

第7章 世界のバセドウ病市場、流通チャネル別、2019～2031年（100万米ドル）

第8章 世界のバセドウ病市場、地域別、2019～2031年、（100万米ドル）

第9章 競合情勢

第10章 アナリストの推奨事項

第11章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Graves' Disease (Overactive Thyroid) Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Graves' Disease (Overactive Thyroid) Market, By Treatment, 2019 - 2031, (USD Mn)

6. Global Graves' Disease (Overactive Thyroid) Market, By Route of Administration, 2019 - 2031, (USD Mn)

7. Global Graves' Disease (Overactive Thyroid) Market, By Distribution Channel, 2019 - 2031, (USD Mn)

8. Global Graves' Disease (Overactive Thyroid) Market, By Region, 2019 - 2031, (USD Mn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

第1章調査の目的と前提条件

第2章市場展望

第3章市場力学、規制、動向分析

第4章世界のバセドウ病市場-コロナウイルス（COVID-19）パンデミックの影響

第5章世界のバセドウ病市場、治療法別、2019～2031年、（100万米ドル）

第6章世界のバセドウ病市場、投与経路別、2019～2031年、（100万米ドル）

第7章世界のバセドウ病市場、流通チャネル別、2019～2031年（100万米ドル）

第8章世界のバセドウ病市場、地域別、2019～2031年、（100万米ドル）

第9章競合情勢

第10章アナリストの推奨事項

第11章参考文献と調査手法